UNIGE document Scientific Article
previous document  unige:26878  next document
add to browser collection

Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease

Authors show hidden authors show all authors [1 - 9]
Published in Journal of proteomics. 2012, vol. 75, no. 15, p. 4656-67
Abstract Despite decades of intensive investigations, the precise sequence of molecular events and the specific proteins mediating the degenerative process underlying Parkinson's disease (PD) remain unraveled. Proteomic strategies may provide unbiased tools to identify novel candidates and explore original mechanisms involved in PD. Substantia nigra pars compacta (SN) tissue, whose degeneration is the hallmark of PD, was dissected from neuropathologically confirmed PD patients (n=3) and control subjects (n=3), before being submitted to a comparative 2-DE analysis. The present study revealed a subset of neuronal and/or glial proteins that appears to be deregulated in PD and likely to contribute to neurodegeneration. Observed alterations not only consolidate well accepted concepts surrounding PD pathogenesis such as oxidative stress and mitochondrial dysfunction but also point out to novel pathways. Among the latter, cytosolic non specific dipeptidase 2 (CNDP2), a relatively unknown protein not yet reported to be associated with PD pathogenesis, was shown to be increased in the SN of PD patients, as confirmed by Western blot. Immunohistochemical analyses demonstrated the presence of CNDP2 within the cytoplasm of SN dopaminergic neurons. Altogether, our findings support a key role of CNDP2 in PD neurodegeneration, by mechanisms that could involve oxidative stress, protein aggregation or inflammation. This article is part of a Special Issue entitled: Translational Proteomics.
Keywords AgedAged, 80 and overDipeptidases/biosynthesisDopaminergic Neurons/metabolism/pathologyFemaleGene Expression Regulation, EnzymologicHumansImmunohistochemistry/methodsInflammation/metabolism/pathologyMaleNerve Tissue Proteins/metabolismNeuroglia/metabolism/pathologyOxidative StressParkinson Disease/metabolism/pathologyProteomeSubstantia Nigra/metabolism/pathology
PMID: 22410244
Full text
Article (Published version) (1.5 MB) - document accessible for UNIGE members only Limited access to UNIGE
Research groups Chimie et protéomique clinique (270)
Groupe Pierre Burkhard (neurologie) (154)
Groupe de Protéomique biomédicale (635)
(ISO format)
LICKER, Virginie et al. Proteomic profiling of the substantia nigra demonstrates CNDP2 overexpression in Parkinson's disease. In: Journal of proteomics, 2012, vol. 75, n° 15, p. 4656-67. doi: 10.1016/j.jprot.2012.02.032 https://archive-ouverte.unige.ch/unige:26878

502 hits



Deposited on : 2013-03-19

Export document
Format :
Citation style :